Resources
-
Publications
- Moving Beyond Population Averages: A Patient-Centered Research Agenda Advancing Personalized Medicine
- Understanding Genomic Testing Utilization and Coverage in the US
- Personalized Medicine at FDA: An Annual Research Report
- The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments: Key Findings and Implications
- A Consumer's Guide to Genetic Health Testing
- The Personalized Medicine Report: An Annual Overview of the Field
- Personalized Medicine in Brief: A Bi-Annual Progress Report
- Personalized Medicine by the Numbers: A Fact Sheet
- Biopharmaceutical Companies' Personalized Medicine Research: A Backgrounder
- Public Perspectives on Personalized Medicine: A Survey of U.S. Public Opinion
- Pathways for Oversight of Diagnostics: A White Paper
- Personalized Medicine and Value Assessment Frameworks: A White Paper
- The Future of Coverage and Payment for Personalized Medicine Diagnostics: A White Paper
- Paying for Personalized Medicine: A White Paper
- Personalized Medicine in the Clinic: A Research Report
Resources
Paying for Personalized Medicine: How Alternative Payment Models Could Help or Hinder the Field
Launch Event Video
Background
In this white paper, titled Paying for Personalized Medicine: How Alternative Payment Models Could Help or Hinder the Field, PMC encourages health care policymakers to consider how alternative payment models (APMs) may promote or impede access to personalized medicine tests and treatments. The paper explores the potential impact of Accountable Care Organizations (ACOs), bundled payments, medical homes and clinical pathways on personalized medicine's development.
Join Today
PMC members shape and advance the future of personalized medicine.
Join Today
Read More
Talk to Us